Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors (EUNASS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04675346|
Recruitment Status : Recruiting
First Posted : December 19, 2020
Last Update Posted : December 22, 2020
This is a prospective, multi-centred cohort study whereby the EUNASS Study questionnaire will be administered electronically to identify needs of melanoma survivors, the extent to which these needs are being met, and identify areas which have the greatest need for development. It will also evaluate behaviour in relation to sun protection and skin self-examination (SSE). It will be a self-completed questionnaire.
Qualitative work using semi-structured interviews will explore the needs of melanoma survivors in greater depth, will present examples of potential interventions to improve SSE and explore factors that determine the likelihood of engaging in an intervention which can address unmet needs, such as improving SSE. Taken together, the data will provide the evidence base to inform the development of an intervention to improve SSE, which can subsequently be tested in secondary care services.
|Condition or disease||Intervention/treatment|
|Melanoma, Stage I Melanoma Stage III Melanoma, Stage II||Other: Questionnaire|
|Study Type :||Observational|
|Estimated Enrollment :||225 participants|
|Official Title:||Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors|
|Actual Study Start Date :||November 18, 2020|
|Estimated Primary Completion Date :||November 17, 2021|
|Estimated Study Completion Date :||November 17, 2022|
The EUNASS Study Questionnaire is an electronic questionnaire (using the Qualtrics programme) designed to assess management after diagnosis of melanoma and during follow-up, health status, fear of melanoma recurrence, melanoma-specific supportive care needs, sun protection behaviour, views and habits about SSE and standard socio-demographic details.
A qualitative researcher will undertake 25-30 semi-structured interviews with participants who have volunteered their contact details in the final section of the EUNASS Study Questionnaire. A purposive sampling approach will be taken for participant recruitment to this part of the study.
- Mixed methods: analysis of a) Patient questionnaire responses and b) Semi-structured interviews [ Time Frame: 2 years ]Mixed methods analysis - quantitative and qualitative results
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04675346
|Contact: Melanie Westmoreland||01865 firstname.lastname@example.org|
|Contact: Rubeta Matin, FRCPemail@example.com|
|Headington, Oxford, United Kingdom, OX3 7LE|
|Contact: Rubeta N Matin, PhD FRCP|
|Principal Investigator:||Rubeta Matin||Oxford University Hospitals NHS Trust|